Pharmacytimes: Resources: Hepatitis Hepatitis en-us Sat, 23 Feb 2019 03:33:36 UTC Sat, 23 Feb 2019 03:33:36 UTC Trending News Today: Supreme Court Rejects Case on Drug Price Gouging Law Top news of the day from across the health care landscape. Hepatitis C Antivirals Reduce All-Cause Mortality, Liver Cancer Longitudinal study of direct-acting antivirals for hepatitis C virus infection finds that treatment provides clinical benefit beyond virologic response, reducing risk for both all-cause mortality and for liver cancer. Trending News Today: Keytruda Fails to Slow Disease, Extend Survival in Liver Cancer Trial Top news of the day across the health care landscape. Trending News Today: Liver Fibrosis Treatment Achieves Main Goal of Late-Stage Study Top news of the day across the health care landscape. New Therapy Able to Clear Hepatitis C From Donor Lungs Prior to Transplantation A novel method of inactivating hepatitis C virus in donor lungs could increase transplantations for patients with end stage lung disease. Sofosbuvir-Based Regimens Well Tolerated in Asian American Patients with HCV Sofosbuvir-based regimens for the treatment of hepatitis C were well tolerated in Asian American communities, according to a new study. Study: Hepatitis B Virus Increases Risk of Age-Related Macular Degeneration Those with hepatitis B virus have a significantly elevated risk for developing any type of age-related macular degeneration, according to a new report Universal Hepatitis C Screening Shows Benefits Over Current Guidelines Analysis finds universal screening for hepatitis C virus infection would be cost effective and provide greater benefit than the currently recommended birth cohort screening. Abuse-Deterrent Formulation of OxyContin Linked to Surge in Hepatitis C Infection Injection drug use has been identified as a predominant risk factor for hepatitis C infection and the opioid epidemic has been suggested as a driver of a recent rise in infections. HIV Increases Mortality Risk in Patients With Hepatocellular Carcinoma HIV-positive patients with hepatocellular carcinoma had an adjusted 24% increased hazard of death compared to their HIV-negative peers. Analysis Estimates Impact of Interventions on Global HCV Epidemic Scaling up prevention, treatment, and screening interventions can make substantial strides toward global hepatitis C elimination. The Importance of Hepatitis C Care After a Cure Post-cure care for hepatitis C can reduce the risk of liver disease progression in those with advanced fibrosis and ongoing risk factors for liver injury. Study: Many Cancer Patients Unaware of Hepatitis Infections Universal hepatitis screening may be warranted to identify patients with cancer who have undiagnosed viral infections. Trending News Today: Alcohol-Related Disease Beats Hepatitis C as Leading Cause for Liver Transplant Top news of the day across the health care landscape Three New Strains of Hepatitis C Virus Create Greater Challenges Clear differences in hepatitis C virus worldwide indicate the need to increase global understanding of the virus. New Treatment Option for Advanced Liver Cancer Tops SPT Week in Review Top news of the week from Specialty Pharmacy Times. Fewer Than 1% of US Population Currently Infected With Hepatitis C Understanding the rate of hepatitis C infection is critical for making strategies to reduce the disease burden among specific populations. Mapping Transmission Core Areas Boosts Targeted Hepatitis C Therapy Application of core area methodology can help identify new hepatitis C cases and outbreaks and improve testing and treatment. FDA OKs Cabozantinib for Previously-Treated Hepatocellular Carcinoma Cabozantinib’s new indication provides an additional therapeutic option for patients with advanced liver cancer who have been previously treated with sorafenib. Injection Drug Users Not Accurately Reporting HIV Status People who inject drugs may not accurately self-report HIV and antiretroviral drug status when entering an HIV prevention study. VSEO N/A